Dataset Information
ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson's Disease.
Ontology highlight
ABSTRACT: Background
Parkinson's disease (PD) is the second commonest neurodegenerative disease. The genetic basis of PD is indisputable. Both ADORA2A rs5760423 and CYP1A2 rs762551 have been linked to PD, to some extent, but the exact role of those polymorphisms in PD remains controversial.Objective
We assessed the role of ADORA2A rs5760423 and CYP1A2 rs762551 on PD risk.Methods
We genotyped 358 patients with PD and 358 healthy controls for ADORA2A rs5760423 and CYP1A2 rs762551. We also merged and meta-analyzed our data with data from previous studies, regarding these two polymorphisms and PD.Results
No significant association with PD was revealed (p > 0.05), for either ADORA2A rs5760423 or CYP1A2 rs762551, in any of the examined genetic model of inheritance. In addition, results from meta-analyses yield negative results.Conclusions
Based on our analyses, it appears rather unlikely that ADORA2A rs5760423 or CYP1A2 rs762551 is among the major risk factors for PD, at least in Greek patients with PD.
SUBMITTER: Siokas V
PROVIDER: S-EPMC7864159 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
Publications
<i>ADORA2A rs5760423</i> and <i>CYP1A2 rs762551</i> Polymorphisms as Risk Factors for Parkinson's Disease.
Journal of clinical medicine 20210120 3
<h4>Background</h4>Parkinson's disease (PD) is the second commonest neurodegenerative disease. The genetic basis of PD is indisputable. Both <i>ADORA2A rs5760423</i> and <i>CYP1A2 rs762551</i> have been linked to PD, to some extent, but the exact role of those polymorphisms in PD remains controversial.<h4>Objective</h4>We assessed the role of <i>ADORA2A rs5760423</i> and <i>CYP1A2 rs762551</i> on PD risk.<h4>Methods</h4>We genotyped 358 patients with PD and 358 healthy controls for <i>ADORA2A rs ...[more]
